セッション情報

FACO International Workshop

第53回・2015年・京都
FACO International Workshop
FACO International Workshop 10
Lung Cancer
開催回
第53回・2015年・京都

Randomized phase III study of nedaplatin plus docetaxel (ND) versus cisplatin plus docetaxel (CD) for advanced or relapsed squamous cell carcinoma of the lung (SqLC): WJOG5208L

演題番号 : FWS10-1

Goto Koichi:1、Shukuya Takehito:2、Yamanaka Takeharu:3、Murakami Haruyasu:4、Yokota Soichiro:5、Kaneda Hiroyasu:6、Kawaguchi Tomoya:7、Nagase Seisuke:8、Oguri Tetsuya:9、Iwamoto Yasuo:10、Nishimura Takashi:11、Hattori Yoshihiro:12、Nakagawa Kazuhiko:6、Nakanishi Yoichi:13、Yamamoto Nobuyuki:14

1:Division of Thoracic Oncology, National Cancer Center Hospital East、2:Department of Respiratory Medicine, Faculty of Medicine, Juntendo University、3:Department of Biostatistics, School of Medicine, Yokohama City University、4:Division of Thoracic Oncology, Shizuoka Cancer Center、5:Department of Respiratory Medicine, National Hospital Organization Toneyama National Hospital、6:Department of Medical Oncology, Faculty of Medicine, Kinki University、7:Department of Respiratory Medicine, Graduate School of Medicine, Osaka City University、8:Department of Thoracic Surgery, Tokyo Medical University、9:Department of Respiratory Medicine, Allergy and Clinical Immunology, Graduate School of Medical Sciences, Nagoya City University、10:Department of Medical Oncology, Hiroshima City Hospital、11:Department of Respiratory Medicine, Kyoto-Katsura Hospital、12:Department of Thoracic Oncology, Hyogo Cancer Center、13:Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University、14:Third Department of Internal Medicine, Wakayama Medical University

Randomized phase III study of nedaplatin plus docetaxel (ND) versus cisplatin plus docetaxel (CD) for advanced or relapsed squamous cell carcinoma of the lung (SqLC): WJOG5208L

Withdrawn

演題番号 : FWS10-2

Withdrawn

Effect of age on adjuvant chemotherapy after resection of non-small cell lung cancer

演題番号 : FWS10-3

Zhai Xiaoyu:1、Wang Ziping:1

1:Department of Medical Oncology, Cancer Hospital Chinese Academy of Medical Sciences

Effect of age on adjuvant chemotherapy after resection of non-small cell lung cancer

Is there an optimal time to initiate adjuvant chemotherapy in order to predict the benefit of survival in non-small cell lung cancer?

演題番号 : FWS10-4

Zhai Xiaoyu:1、Wang Ziping:1

1:Department of Medical Oncology, Cancer Hospital Chinese Academy of Medical Sciences

Is there an optimal time to initiate adjuvant chemotherapy in order to predict the benefit of survival in non-small cell lung cancer?

RAB11A expression is associated with poor prognosis and malignant phenotypes in human lung squamous cell carcinoma

演題番号 : FWS10-5

Azuma Yoko:1、Mogi Akira:1、Yokobori Takehiko:1,2、Iijima Misaki:1、Onozato Ryoichi:1、Yajima Toshiki:1、Kuwano Hiroyuki:1

1:Department of General Surgical Science, Graduate School of Medicine, Gunma University、2:Department of Molecular Pharmacology and Oncology, Graduate School of Medicine, Gunma University

RAB11A expression is associated with poor prognosis and malignant phenotypes in human lung squamous cell carcinoma

Drastic morphological and molecular differences between lymph node micrometastatic tumors and macrometastatic tumors of lung adenocarcinoma

演題番号 : FWS10-6

Aramaki Nao:1,2,3、Ishii Genichiro:3、Yamada Eiji:2,3、Aokage Keiju:2、Kojima Motohiro:3、Hishida Tomoyuki:2、Yoshida Junji:2、Ochiai Atsushi:3、Tsuboi Masahiro:2、Ikeda Norihiko:1

1:Division of General Thoracic Surgery, Tokyo Medical University、2:Division of Thoracic Surgery, National Cancer Center Hospital East、3:Division of Pathology, Rsearch Center for Innovative Oncology, National Cancer Center Hospital East

Drastic morphological and molecular differences between lymph node micrometastatic tumors and macrometastatic tumors of lung adenocarcinoma